Avonex 30 MCG/0.5 ML SYR (4PK)s
Ended Awarded
- Contract number
- SPE2DB25FRDAH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,635
Award facts
- Contract value 100% obligated
- $30,634.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,634.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of AVONEX 30 micrograms per 0.5 milliliter syringes in four-packs. This non-set-aside competitive award is scheduled for completion by August 21, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle—specifically the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program—which provides AmerisourceBergen with a comprehensive platform to supply pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that regularly fulfills delivery orders for the Defense Logistics Agency across a broad spectrum of therapeutic categories. This delivery order for AVONEX, an interferon beta-1a injectable medication used primarily in the treatment of multiple sclerosis, reflects the company's established role as a key supplier of specialty pharmaceutical products to the Defense Health Agency and other military healthcare stakeholders. The underlying indefinite delivery contract is valued at $999,999,999.00 through December 2026, positioning AmerisourceBergen as one of the primary pharmaceutical vendors supporting the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRDAH?
SPE2DB25FRDAH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FRDAH worth?
The government has obligated $30,635 on SPE2DB25FRDAH.
Is contract SPE2DB25FRDAH an order under another contract?
Yes. SPE2DB25FRDAH is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRDAH competed?
The extent of competition for SPE2DB25FRDAH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award